O=[N+]([O-])c1ccc(C2[C@H]3C(c4ccccc4)=NC4(CCCCC4)N23)cc1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?